ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,526, issued on April 21.
"Substituted salicylamide compounds and use thereof" was invented by Yanming Wang (Suzhou, China), Yan Xia (Suzhou, China), Zhengwei Guo (Suzhou, China), Jinquan Sun (Suzhou, China) and Mingde Xia (Suzhou, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a compound or a pharmaceutically acceptable salt, prodrug, or metabolite thereof, or a solvate or hydrate of any of the foregoing and a use in treatment of a disease or disorder."
The patent was filed on Jan. 10, 2022, under Application No. 18/260,703.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netac...